Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Using MRI scans to target biopsies is more effective at detecting prostate cancers that are likely to need treatment than standard ultrasound guided biopsies alone, according to research published on 7 August in JAMA Network Open. The research, led by the National Institute for Health Research (NIHR) and Universities of Bristol, Ottawa, Exeter and Oxford, combined the results from seven studies covering 2,582 patients.

Load More

Similar stories

Success for researchers at the CRUK Oxford Centre Symposium

Congratulations to Dr Wencheng Yin and Sophia Abusamra who were awarded winner and runner-up respectively in the poster presentation competition at the 2024 CRUK Oxford Centre – Oxford Cancer Symposium on Wednesday 13 March.